Achieve Clinical Research — research payments reported

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$5,993	4
2024	Research	$15	1
2021	Research	$2,500	1
2019	Research	$3,747	4

Breakdown

Who paid Research payments · program years 2019–2025

Seqirus USA Inc $5,993 4 payments
AstraZeneca Pharmaceuticals LP $2,500 1 payment
Noven Pharmaceuticals, Inc. $2,300 2 payments
GlaxoSmithKline, LLC. $1,447 2 payments
Novartis Pharmaceuticals Corporation $15 1 payment

Studies the money was for Research payments · program years 2019–2025

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults 65 Years of Age $5,993 4 payments
Onset of Effect Questionnaire $2,500 1 payment
A 4-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of Hp-5000 in Subjects With Osteoarthritis Oa of the Knee. $2,300 2 payments
A Phase 3/4, Multi-Center, Randomized, Double-Blind, Placebo-Controlle $1,379 1 payment
A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess $68 1 payment
A Randomized, Double-Blind, Placebo Controlled, 3-Arm Multicenter Phase 3 Study to Assess the Efficacy and Safety of Ianalumab in Patients With Active Sjogren's Syndrome (Neptunus-2) $15 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.